First-line treatment of EGFR-mutated nonsmall cell lung cancer: critical review on study methodology

Martin Sebastian, Alexander Schmittel, Martin Reck
European Respiratory Review 2014 23: 92-105; DOI: 10.1183/09059180.00008413

Article Information

vol. 23 no. 131 92-105
DOI 
https://doi.org/10.1183/09059180.00008413
PubMed 
24591666
Published By 
European Respiratory Society
Print ISSN 
0905-9180
Online ISSN 
1600-0617
History 
  • Received November 29, 2013
  • Accepted December 20, 2013
  • Published online February 28, 2014.
Copyright & Usage 
©ERS 2014 ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 3.0.

Author Information

  1. Martin Sebastian1⇑,
  2. Alexander Schmittel2 and
  3. Martin Reck3
  1. 1Dept of Hematology/Oncology, University Hospital Frankfurt, Frankfurt, 2Hematology, Oncology, Infectious Diseases, Aerzteforum Seestrasse, Medizinisches Versorgungszentrum, Berlin, and 3LungClinic Grosshansdorf, Member of the German Centre for Lung Research (DZL), Grosshansdorf, Germany.
  1. M. Sebastian, Dept of Hematology/Oncology, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Frankfurt, Germany. E-mail: martin.sebastian{at}kgu.de
View Full Text

Article usage

Article usage: March 2014 to April 2022

AbstractFullPdf
Feb 20141623
Mar 20141079585526
Apr 2014501329213
May 2014343251120
Jun 2014176233102
Jul 2014132250105
Aug 2014128190105
Sep 201413322390
Oct 201410631596
Nov 2014146343167
Dec 20148721579
Jan 201511130579
Feb 20157235366
Mar 201510532586
Apr 201510621563
May 201576282104
Jun 20156830767
Jul 20157220767
Aug 20156216752
Sep 201544211126
Oct 20151821967
Nov 20151219780
Dec 20151516472
Jan 20162222387
Feb 2016815548
Mar 20161917464
Apr 20161416195
May 2016812841
Jun 201639941
Jul 20161411349
Aug 20161311459
Sep 20161511833
Oct 20162017267
Nov 201619100165
Dec 20161329754
Jan 2017517036
Feb 2017813056
Mar 20171715768
Apr 2017919632
May 2017815430
Jun 2017615421
Jul 2017414829
Aug 2017715328
Sep 2017612524
Oct 2017525227
Nov 2017515113
Dec 2017817527
Jan 2018513715
Feb 20181810826
Mar 2018810521
Apr 2018110818
May 2018310522
Jun 201868811
Jul 201847622
Aug 2018911814
Sep 2018218210
Oct 2018223452
Nov 2018036916
Dec 2018430211
Jan 2019510113
Feb 2019178514
Mar 20191110518
Apr 201947823
May 20199729
Jun 20197549
Jul 20194469
Aug 2019410113
Sep 2019711712
Oct 201946510
Nov 20195737
Dec 201965712
Jan 202038313
Feb 202046414
Mar 202005318
Apr 202035923
May 202067016
Jun 202035323
Jul 202034615
Aug 202034430
Sep 202015120
Oct 202005426
Nov 202025623
Dec 202026813
Jan 202115418
Feb 202137027
Mar 202127115
Apr 202125919
May 202114424
Jun 20212395
Jul 202123117
Aug 202144420
Sep 202155415
Oct 202116245
Nov 202114038
Dec 202143836
Jan 202233513
Feb 2022106519
Mar 20224529
Apr 202226717

Altmetrics

Back to top
View this article with LENS
Email
Print
Citation Tools

First-line treatment of EGFR-mutated nonsmall cell lung cancer: critical review on study methodology
Martin Sebastian, Alexander Schmittel, Martin Reck
European Respiratory Review Mar 2014, 23 (131) 92-105; DOI: 10.1183/09059180.00008413
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

Subjects